{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidxel7opza4x2a3wzrfohtpn4c6g7ssnyoz6twtennivxk2kr7rsu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfrtbne2c722"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihpmov53lihvdr6y62dfz7k6zvaa3seahpbjlt73z6uianbapvea4"
    },
    "mimeType": "image/jpeg",
    "size": 456342
  },
  "path": "/news/2026-02-drug-invasive-breast-cancer.html",
  "publishedAt": "2026-02-26T13:00:05.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical trials. The study is published in Cancer Research.",
  "title": "A promising new drug for an invasive type of breast cancer"
}